Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pancreas ; 24(3): 264-8, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11893934

RESUMO

INTRODUCTION: Recent data from experimental and clinical studies suggest that the antibiotics showing good penetration into the pancreas may reduce mortality by preventing pancreatic infection, which is the most important prognostic factor in acute pancreatitis. AIM: To determine and compare pancreatic tissue concentrations of meropenem and cefepime at different stages of acute necrotizing pancreatitis in an animal model that has been shown to closely mimic severe human pancreatitis. METHODOLOGY: Acute necrotizing pancreatitis was induced in rats by a standardized intraductal infusion of glycodeoxycholic acid and intravenous cerulein. Six hours (n = 30) and 48 hours (n = 30) after induction of pancreatitis, the rats were randomized to receive an intravenous 20 mg/kg injection of either meropenem or cefepime. Blood and the head of the pancreas were collected for determining antibiotic concentrations by high-performance liquid chromatography. RESULTS: Meropenem concentrations in the pancreas at 6 hours of acute pancreatitis increased significantly and decreased at 48 hours of the disease, but were still higher than that in controls. Concentrations of cefepime in necrotic pancreatic tissue were significantly low either during the initial or later phase, but lower in latter, in which the necrosis was more evident. Tissue/serum concentration ratios of meropenem were significantly higher than those of cefepime. However, tissue concentrations of both antibiotics are much higher than the minimum inhibitory concentration values for the common microorganisms involved in pancreatic infections. CONCLUSION: Although both antibiotics penetrate into the necrotic tissue in sufficient therapeutic concentrations, penetration of meropenem is much better than cefepime. However, good tissue penetration may not solely indicate efficacy of that antibiotic. Therefore, further experimental and clinical studies are needed to determine the therapeutic and prognostic efficacy of these agents.


Assuntos
Antibacterianos/farmacocinética , Cefalosporinas/farmacocinética , Pâncreas/metabolismo , Pancreatite Necrosante Aguda/induzido quimicamente , Pancreatite Necrosante Aguda/metabolismo , Tienamicinas/farmacocinética , Animais , Cefepima , Cefalosporinas/sangue , Ceruletídeo/administração & dosagem , Cromatografia Líquida de Alta Pressão , Ácido Glicodesoxicólico/administração & dosagem , Masculino , Meropeném , Pâncreas/química , Pâncreas/patologia , Ratos , Ratos Sprague-Dawley , Tienamicinas/sangue
2.
Indian J Gastroenterol ; 21(1): 4-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11871842

RESUMO

BACKGROUND: There has been considerable interest in gall bladder motility in recent years. We compared the effects of cholecystokinin (CCK) and erythromycin on bile chemistry and gallstone formation in aged guinea pigs. METHODS: Two groups of guinea pigs (1-mo and 3-y old; n=40 each) were studied. Each group was divided into four subgroups of 10 animals each; one subgroup received lithogenic diet, one each received CCK or erythromycin daily in addition to lithogenic diet for 4 weeks, and one received normal diet. After 4 weeks, the presence of gallstones or sludge was recorded and bile composition including concentrations of bile acid, cholesterol, lecithin and protein concentrations was studied. RESULTS: No gallstones were observed in the 1-mo-old animals. In the 3-year-old animals, 9 of 10 guinea pigs on lithogenic diet and 4 of 10 in each treatment subgroup and the normal diet subgroup developed gallstones. CCK and erythromycin had similar effects on bile chemistry and stone formation. CONCLUSIONS: Aging increases the formation of gallstones in guinea pigs. Erythromycin is as effective as CCK in reducing gallstone formation by improving gall bladder motility.


Assuntos
Bile/efeitos dos fármacos , Colelitíase/prevenção & controle , Eritromicina/análogos & derivados , Eritromicina/farmacologia , Esvaziamento da Vesícula Biliar/efeitos dos fármacos , Sincalida/farmacologia , Envelhecimento/fisiologia , Animais , Bile/química , Ácidos e Sais Biliares/análise , Colelitíase/etiologia , Colelitíase/fisiopatologia , Colesterol/análise , Colesterol na Dieta/administração & dosagem , Eritromicina/uso terapêutico , Cobaias , Masculino , Fosfatidilcolinas/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...